McDermott Will & Schulte LLP
McDermott Will & Schulte LLP filed a Q4 report for Surescripts on January 14, 2026, reporting $30,000 in lobbying income.
Lobbying for Surescripts · Health IT Company
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote equitable community access to pharmacist services.